Works matching IS 02683369 AND DT 2004 AND VI 33 AND IP 2

Results: 21

Cytogenetic clonal evolution alone in CML relapse post-transplantation does not adversely affect response to imatinib mesylate treatment.

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 237, doi. 10.1038/sj.bmt.1704332

By:

Y. J. Kim;
D.- W. Kim;
S. Lee;
Y.- L. Kim;
J.- Y. Hwang;
Y.- H. Park;
H.- J. Kim;
J.- W. Lee;
W.- S. Min;
C.- C. Kim

Publication type:

Article

Nonmyeloablative allogenic peripheral-blood stem-cell transplantation in pancreatic adenocarcinoma: one case, high expectations.

Published in:

2004

By:

Laghi, L.;
Castagna, L.;
Malesci, A.

Publication type:

Letter

HistoCheck: rating of HLA class I and II mismatches by an internet-based software tool.

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 165, doi. 10.1038/sj.bmt.1704301

By:

Elsner, H.- A.;
DeLuca, D.;
Strub, J.;
Blasczyk, R.

Publication type:

Article

Secondary Philadelphia chromosome after non-myeloablative peripheral blood stem cell transplantation for a myelodysplastic syndrome in transformation.

Published in:

2004

By:

Prebet, T.;
Michallet, A. S.;
Charrin, C.;
Hayette, S.;
Magaud, J.- P.;
Thiébaut, A.;
Michallet, M.;
Nicolini, F. E.

Publication type:

Letter

Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors.

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 171, doi. 10.1038/sj.bmt.1704341

By:

Topcuoglu, P.;
Arat, M;
Dalva, K.;
Özcan, M

Publication type:

Article

Late cytomegalovirus polyradiculopathy following haploidentical CD34<sup>+</sup>-selected hematopoietic stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 243, doi. 10.1038/sj.bmt.1704311

By:

Zeiser, R.;
Grüllich, C.;
Bertz, H.;
Pantazis, G.;
Hufert, F. T.;
Bley, T. A.;
Finke, J.

Publication type:

Article

Prompt initiation of immunotherapy in children with an increasing number of autologous cells after allogeneic HCT can induce complete donor-type chimerism: a report of 14 children.

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 211, doi. 10.1038/sj.bmt.1704321

By:

Gorczyñska, E.;
Turkiewicz, D.;
Toporski, J.;
Kalwak, K.;
Rybka, B.;
Ryczan, R.;
Sajewicz, L.;
Chybicka, A.

Publication type:

Article

Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know.

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 137, doi. 10.1038/sj.bmt.1704316

By:

Leather, H. L.

Publication type:

Article

Donor commitment and patient needs.

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 225, doi. 10.1038/sj.bmt.1704323

By:

Bakken, R.;
Van Walraven, A.- M.;
Egeland, T.

Publication type:

Article

Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia.

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 205, doi. 10.1038/sj.bmt.1704324

By:

Frisk, P.;
Arvidson, J.;
Gustafsson, J.;
Lönnerholm, G.

Publication type:

Article

Autologous stem cell transplantation for acute myelogenous leukemia in first complete remission: a 6-year follow-up study of 101 patients from a single institution.

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 177, doi. 10.1038/sj.bmt.1704326

By:

Vey, N.;
Bouabdallah, R.;
Stoppa, A.;
Faucher, C.;
Lafage, M.;
Chabannon, C.;
Sainty, D.;
Gastaut, J.;
Maraninchi, D.;
Blaise, D.

Publication type:

Article

A pilot study of cytoreductive chemotherapy combined with infusion of additional peripheral blood stem cells reserved at time of harvest for transplantation in case of relapsed hematologic malignancies after allogeneic peripheral blood stem cell transplant

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 231, doi. 10.1038/sj.bmt.1704328

By:

J. G. Kim;
S. K. Sohn;
D. H. Kim;
N. Y. Lee;
J. S. Suh;
K. S. Lee;
K. B. Lee

Publication type:

Article

Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention.

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 189, doi. 10.1038/sj.bmt.1704329

By:

Corbacioglu, S.;
Greil, J.;
Peters, C.;
Wulffraat, N.;
Laws, H. J.;
Dilloo, D.;
Strahm, B.;
Gross-Wieltsch, U.;
Sykora, K. W.;
Ridolfi-Lüthy, A.;
Basu, O.;
Gruhn, B.;
Güngör, T.;
Mihatsch, W.;
Schulz, A. S.

Publication type:

Article

Successful reduced-intensity HLA-haploidentical stem cell transplantation based on the concept of feto-maternal tolerance for an elderly patient with myelodysplastic syndrome.

Published in:

2004

By:

Obama, K.;
Takemoto, Y.;
Takatsuka, Y.;
Utsunomiya, A.

Publication type:

Letter

Influence of cytomegalovirus (CMV) sero-positivity on CMV infection, lymphocyte recovery and non-CMV infections following T-cell-depleted allogeneic stem cell transplantation: a comparison between two T-cell depletion regimens.

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 197, doi. 10.1038/sj.bmt.1704334

By:

Chakrabarti, S.;
Milligan, D. W.;
Brown, J.;
Osman, H.;
Vipond, I. B.;
Pamphilon, D. H.;
Marks, D. I.

Publication type:

Article

Toward a myeloablative regimen with clinical potential: II. Treosulfan induces specific skin graft tolerance across haploidentical MHC barriers.

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 153, doi. 10.1038/sj.bmt.1704333

By:

Van Pel, M.;
Van Breugel, D. W. J. G.;
Vos, W.;
Ploemacher, R. E.;
Boog, C. J. P.

Publication type:

Article

Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 183, doi. 10.1038/sj.bmt.1704335

By:

Pérez-Simón, J. A.;
García-Escobar, I.;
Martinez, J.;
Vazquez, L.;
Caballero, D.;
Cañizo, C.;
Mateos, M. V.;
San Miguel, J. F.

Publication type:

Article

Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia.

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 219, doi. 10.1038/sj.bmt.1704337

By:

Hoelle, W.;
Beck, J. F.;
Dueckers, G.;
Kreyenberg, H.;
Lang, P.;
Gruhn, B.;
Führer, M.;
Niethammer, D.;
Klingebiel, T.;
Bader, P.

Publication type:

Article

Urgent need for a validated tumor response evaluation system for use in immunotherapy.

Published in:

2004

By:

Hori, A.;
Kami, M.;
Kim, S. W.;
Murashige, N.;
Sakiyama, M.;
Kojima, R.;
Hamaki, T.;
Makimoto, A.;
Miyakoshi, S.;
Masuo, S.;
Taniguchi, S.;
Kunitoh, H.;
Takaue, Y.

Publication type:

Letter

Ideal or actual body weight to calculate CD34+ cell doses for allogeneic hematopoietic stem cell transplantation?

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 2, p. 161, doi. 10.1038/sj.bmt.1704388

By:

Cilley, J.;
Rihn, C.;
Monreal, J.;
Gordon, L. I.;
Singhal, S.;
Tallman, M.;
Williams, S.;
Winter, J.;
Mehta, J.

Publication type:

Article

Reply to the letter by Hori et al.

Published in:

2004

By:

Barkholt, L.;
Hentschke, P.;
Ringdén, O.

Publication type:

Letter